Acclaro Medical to Highlight UltraClear 2910-nm Cold Fiber Laser at ASDS 2026
Key Takeaways
- Acclaro Medical will showcase its UltraClear 2910-nm cold ablative fiber laser at the 2026 American Society for Dermatologic Surgery (ASDS) Annual Meeting in San Diego, November 4–8.
- The UltraClear platform is designed for customizable skin resurfacing, with applications ranging from superficial rejuvenation to scar management and Laser-Coring procedures.
- Expert presentations and educational sessions will address ablative resurfacing, laser treatment in skin of color, device settings, and scar management. Clinical outcome data were not provided in the announcement.
Acclaro Medical will showcase its UltraClear 2910-nm cold ablative fiber laser at the 2026 American Society for Dermatologic Surgery (ASDS) Annual Meeting, November 4–8 in San Diego, California, highlighting the technology’s applications in skin resurfacing, rejuvenation, and scar management.
The company describes UltraClear as the first 2910-nm cold ablative fiber laser, designed to provide customizable treatments across multiple skin types, treatment depths, and aesthetic indications.
UltraClear Laser Technology and Clinical Applications
According to Acclaro, UltraClear supports procedures ranging from superficial resurfacing and preventive aesthetic treatments to more intensive interventions, including its proprietary Laser-Coring technique for addressing excess skin.
The platform is designed to treat concerns associated with skin aging, pigmentation, and scarring. Acclaro also reports potential advantages in patient comfort and recovery time, although comparative clinical outcomes were not included in the announcement.
The company’s presence at ASDS will include discussions of ablative resurfacing techniques, laser applications in skin of color, scar management, and treatment customization.
Featured presenters include Joel L. Cohen, MD; Suzanne Kilmer, MD; E. Victor Ross, MD; Roy Geronemus, MD; and Tina Alster, MD, among other dermatologic surgery experts.
Acclaro will also host Fiber Focus Sessions at Booth 527, featuring educational presentations from Cohen, Eric F. Bernstein, MD; Taryn Murray, MD; and Daniel Yanes, MD.
The exhibition will additionally feature AuraLux, another fiber laser platform in Acclaro’s aesthetic device portfolio.
“As the world's first 2910 nm cold ablative fiber laser, UltraClear has established a new category of Skin Health treatments that give physicians remarkable versatility in how they approach skin rejuvenation,” said Shlomo Assa, president of Acclaro Medical.
The announcement did not provide specific efficacy endpoints, patient enrollment figures, or comparative safety data supporting the platform’s proposed clinical advantages.
Source
Acclaro Medical. Acclaro Medical showcases new category of skin resurfacing established by UltraClear, 2910 nm cold fiber laser at ASDS Annual Meeting. PR Newswire. Published November 3, 2026.